NOX 9.52% 11.5¢ noxopharm limited

Ann: Veyonda Patent Lodged for Major Septic Shock Opportunity, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    What we now know:
    • One person dies from Sepsis every 3 seconds – 10 MILLION per year!
    • This is as many as die from ALL forms of cancer each year
    • An effective treatment of Sepsis is a massive opportunity
    • The key is to reduce excessive cytokine levels in a safe and well-tolerated manner
    • Laboratory findings indicate that this is exactly what Veyonda will do
    • Analysis of blood samples from Covid patients treated with Veyonda will show whether excessive cytokine levels HAVE been controlled in humans.
    Noxopharm already knows how NOXCOVID patients reacted to treatment, and my guess is that, at the very least, it has some preliminary data from the blood analysis, otherwise why would it make this announcement just now?

    This is HUGE news, with more to come.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
11.5¢
Change
0.010(9.52%)
Mkt cap ! $33.60M
Open High Low Value Volume
11.0¢ 11.5¢ 10.5¢ $2.964K 26.20K

Buyers (Bids)

No. Vol. Price($)
2 53298 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.5¢ 33616 1
View Market Depth
Last trade - 16.10pm 07/10/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.